IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

DC Funds, LP

Q4 2023 Holdings

Filed 2024-02-13 | 3 holdings | $8.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Tscan Therapeutics Inc(TCRX)COM89854M101$3.7M630,00044.2%
Barinthus Biotherapeutics PL(BRNS)ADS91864C107$2.4M642,20428.5%
Werewolf Therapeutics Inc(HOWL)COM95075A107$2.3M589,10227.3%